ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer

Autor: Alessandro Marra, Thomas Krueer, Olaf M. Koch, U. Bosse, Wolfgang Wagner, Dirk Kemming, Maria Netchaeva, U. Vogt, Ludger Hillejan

Publikováno v: Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Thoraxchirurgie; 20131024-20131026; Basel, Schweiz; DOCS1.7 /20131014/

Objective: Neoadjuvant platinum-based chemotherapy in stage III non-small cell lung cancer (NSCLC) offers the chance to eradicate occult metastases and decrease the tumor volume, thus improving curative surgical resection rates. A remission after ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1387338957a0758b31b727bc7e18ae3
http://www.egms.de/en/meetings/dgt2013/13dgt014.shtml